Wednesday, June 10, 2026

Intelligence · Patents

Patents expiring in 2031

Annual patent cliff calendar for 2031 — US pharmaceutical patents by expiration date.

Patents
902

Quick answer

902 indexed pharmaceutical patents have expiration dates in 2031. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7976853

    Process for producing coated preparation

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7982044

    Iminopyridine derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7982037

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7982011

    Mutated anti-cd22 antibodies and immunoconjugates

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7982014

    FGFR3-IIIc fusion proteins

    Five Prime Therapeutics, Inc. · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7981935

    Stem cell differentiating agents and uses therefor

    The Board of Regents of the University of Texas System · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7981931

    Pharmaceutical compositions of short-acting sedative hypnotic agent

    Theravance, Inc. · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7981869

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7981864

    Methods and compositions for targeting proteins across the blood brain barrier

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7981618

    Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer

    The Board of Regents of the University of Texas System · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7981936

    Crystalline ACAT inhibitor

    Graceway Pharmaceuticals. LLC · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7981610

    ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7981598

    Preventive/remedy for respiratory diseases

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7981409

    Method of reducing aging of skin by applying interleukin-1 alpha

    United Technologies UT AG · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7981439

    Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof

    Acurx Pharmaceuticals, Inc. · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7981513

    Dental filler

    JGC Catalysts and Chemicals Ltd. · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 2011178580

    ENHANCED ANTI-MICROBIAL PDT

    ALBRECHT VOLKER [DE] · Granted Thu Jul 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jul 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7985769

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7985783

    Aldehyde tags, uses thereof in site-specific protein modification

    The Regents of the University of California · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7985601

    Tunable, semi-interpenetrating polymer networks (sIPNS) for medicine and biotechnology

    The Regents of the University of California · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7985748

    ALPHA2C adrenoreceptor agonists

    Pharmacopeia Drug Discovery, Inc. · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7985428

    Method and composition for modulation of systemic inflammatory responses syndrome (SIRS)

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7985581

    Multiple RNA polymerase III promoter expression constructs

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7985887

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7985863

    Iminopyridine derivatives and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7985762

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7985401

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7985862

    Iminopyridine derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7985836

    Antimicrobial peptides and methods of identifying the same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. FR 2955495

    MEDICAMENT POUR LA REDUCTION DE LA CHOLESTEROLEMIE

    BIOCODEX [FR] · Granted Fri Jul 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Jul 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7989500

    Synthesis, methods of using, and compositions of cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7989430

    Antibacterial agents

    Regents of the University of Minnesota · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7989501

    Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7988958

    Enterococcus and Streptococcus strains and bacteriocins

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7988971

    Human monoclonal antibodies against Hendra and Nipah viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7989448

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7989445

    Thienopyrimidone compound

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7988685

    Hydrogel compositions, devices, and microscale components

    Regents of the University of Minnesota · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7988967

    High affinity human antibodies to human nerve growth factor

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7988956

    Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)

    Nektar Therapeutics · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7988977

    Modified live Aeromonas hydrophila vaccine for aquatic animals

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7989481

    Indane derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7989473

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7989456

    Pyrazine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7989498

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7989484

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7993865

    Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen

    The Regents of the University of California · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7993919

    Method of inducing memory B cell development and terminal differentiation

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2031?

902 published patents in our USPTO index have expiration dates falling in calendar year 2031.